For decades, bacterial vaginosis has been treated as a women’s health issue—but new research suggests treating male partners could dramatically cut recurrence rates.

Women experience fewer repeat infections with bacterial vaginosis when both they and their male sex partners receive antibiotics.

A new study suggests that bacterial vaginosis (BV), affecting nearly 1 in 3 women worldwide, should be classified as a sexually transmitted infection (STI). Research shows treating male partners alongside female patients reduces reinfection by 60 per cent,

Bacterial vaginosis, which affects nearly 1 in 3 women, should be considered a sexually transmitted disease, according to a new study.

Health experts say an Australian study linking sexual activity to an infection that 1 in 3 U.S. women contract has provided a new tool to prevent recurrences, as well as find a cure.

A common vaginal infection affecting nearly one in three reproductive-aged women worldwide should be reclassified as a sexually transmitted disease (STD), according to a new study published in the New England Journal of Medicine.

Bacterial vaginosis affects nearly 1 in 3 women of reproductive age. A study adds to evidence it is sexually transmitted, offering a new way to reduce recurrence.

Key Takeaways A new study found treating male partners for a common vaginal infection reduced recurrence by 60%Researchers say bacterial vaginosis (BV) should be considered a sexually transmitted infectionUntreated BV can increase the risk of HIV,